A Phase 1, Single Dose Study of JZP-386 to Evaluate Safety, Pharmacokinetics and Pharmacodynamics

NCT02215499 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Narcolepsy, Excessive Daytime Sleepiness

Interventions

DRUG: Placebo
DRUG: Sodium Oxybate
DRUG: JZP-386

Sponsor

Concert Pharmaceuticals